Human Placental Extract and its Formulations is back in India vide the Gazette Notification No. G.S.R 418(E) dated May 30, 2011 - the Ministry of Health & Family Welfare...... USE OF PLACENTREX CONTINUES!
Related Posts Plugin for WordPress, Blogger...

Sunday, February 20, 2011

Efficacy of Human Placental Extract

While looking for the views on efficacy of human placenta from the researchers outside India, I come up with a few articles available on the net. Would like to share the same. The copyright of the same remains with the respective authority (a link to the original article has been provided)


Clinical assessment of injecting human placental extract into acupuncture points: A case series
Accession number;06A0055986
Title;Clinical assessment of injecting human placental extract into acupuncture points: A case series
Author;NAGASE MAHIKO(Tepposu Shinryosho)  
Journal Title;Eastern Medicine
Journal Code:L0095A
Pub. Country;Japan

Abstract: This study is a retrospective single case series. There are two types of injections containing extract of human placenta, "Melsmon" and "Laennec" available in Japan. Both injections can be covered by health insurance system. Normally "Melsmon" is used for climacterics syndrome and suppression of lactation. (hypogalactia) On the other hand "Laennec" is used for liver dysfunction. Both drugs are injected subcutaneously and intramuscularly. In addition to these methods, injecting human placental extract into acupuncture points is known to have efficacy for various kinds of diseases through many years of clinical experience. On this paper this method's potential of efficacy for many diseases is presented with a discussion of their mechanism of action, and some cases in which they showed remarkable improvement compared with using conventional therapy are also presented. (author abst.)

Courtesy: Science Links Japan


Efficacy and safety of human placenta extract in alleviating climacteric symptoms: prospective, randomized, double-blind, placebo-controlled trial.
Lee YK, Chung HH, Kang SB.

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
AIM: To assess the efficacy and safety of human placenta extract in the relief of climacteric symptoms.

METHODS: A prospective, randomized, double-blind, placebo-controlled trial was performed on 108 women with menopausal symptoms. Human placenta extract or placebo was administered to the women for 4 weeks. Climacteric symptoms were assessed with the Kupperman Index (KMI).

RESULTS: Both groups showed a significant reduction in the KMI score at the end of treatment. However, the decrease in the KMI score was significantly greater in the product group than in the placebo group (-12.30 +/- 10.44 vs -7.15 +/- 9.11, P = 0.012) after 4 weeks of treatment. The level of lipid profiles and liver function tests demonstrated no significant changes before and after treatment in both groups.

CONCLUSION: Human placenta extract reduced climacteric symptoms more than the placebo. The safety evaluation showed a good safety and tolerability profile in the placenta extract group. The results of the present study suggest that human placenta extract can be an alternative therapy in women with menopausal symptoms.

PMID: 20144174 [PubMed - indexed for MEDLINE]

No comments:

Post a Comment